Search research articles
Contact Us
Filters
Showing results (71-80 of 120) with videos related to
Page
of 12
Sort By:
Clinical Pharmacology : Advances and Applications
|
August 14, 2012
Management of antipsychotic treatment discontinuation and interruptions using model-based simulations
Mahesh N Samtani, John J Sheehan, Dong-Jing Fu, et al.
Neuropsychiatric Disease and Treatment
|
March 16, 2013
Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
Larry Alphs, Cynthia A Bossie, Jennifer Kern Sliwa, et al.
Psychiatry Research
|
October 17, 2020
Suicide Ideation and Behavior Assessment Tool (SIBAT): Evaluation of Intra- and Inter-Rater Reliability, Validity, and Mapping to Columbia Classification Algorithm of Suicide Assessment
Larry Alphs, Dong-Jing Fu, David Williamson, et al.
Psychiatric Research and Clinical Practice
|
September 14, 2022
Economic Burden of Treatment-Resistant Depression Among Patients Hospitalized for Major Depressive Disorder in the United States
Jay Lin, Holly Szukis, John J Sheehan, et al.
Current Drug Safety
|
November 5, 2010
Are the long-acting intramuscular formulations of risperidone or paliperidone palmitate associated with post-injection delirium/sedation syndrome? An assessment of safety databases
Larry Alphs, Srihari Gopal, Keith Karcher, et al.
International Clinical Psychopharmacology
|
March 15, 2016
Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy
Larry Alphs, Henry A Nasrallah, Cynthia A Bossie, et al.
International Clinical Psychopharmacology
|
March 11, 2010
Medication satisfaction in schizophrenia: a blinded-initiation study of paliperidone extended release in patients suboptimally responsive to risperidone
Carla M Canuso, Augusto Grinspan, Amir Kalali, et al.
Journal of Medical Economics
|
August 28, 2010
Clinical characteristics and resource utilization of patients with bipolar disorder who have frequent psychiatric interventions
J Thomas Haskins, Wayne Macfadden, Norris Turner, et al.
Journal of Medical Economics
|
April 9, 2015
Cost effectiveness of paliperidone palmitate versus oral antipsychotics in patients with schizophrenia and a history of criminal justice involvement
Erik Muser, Chris M Kozma, Carmela J Benson, et al.
Bipolar Disorders
|
November 20, 2009
A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently
Wayne Macfadden, Larry Alphs, J Thomas Haskins, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 120) with videos related to
Sort By:
Page
of 12
Clinical Pharmacology : Advances and Applications
|
August 14, 2012
Management of antipsychotic treatment discontinuation and interruptions using model-based simulations
Mahesh N Samtani, John J Sheehan, Dong-Jing Fu, et al.
Neuropsychiatric Disease and Treatment
|
March 16, 2013
Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
Larry Alphs, Cynthia A Bossie, Jennifer Kern Sliwa, et al.
Psychiatry Research
|
October 17, 2020
Suicide Ideation and Behavior Assessment Tool (SIBAT): Evaluation of Intra- and Inter-Rater Reliability, Validity, and Mapping to Columbia Classification Algorithm of Suicide Assessment
Larry Alphs, Dong-Jing Fu, David Williamson, et al.
Psychiatric Research and Clinical Practice
|
September 14, 2022
Economic Burden of Treatment-Resistant Depression Among Patients Hospitalized for Major Depressive Disorder in the United States
Jay Lin, Holly Szukis, John J Sheehan, et al.
Current Drug Safety
|
November 5, 2010
Are the long-acting intramuscular formulations of risperidone or paliperidone palmitate associated with post-injection delirium/sedation syndrome? An assessment of safety databases
Larry Alphs, Srihari Gopal, Keith Karcher, et al.
International Clinical Psychopharmacology
|
March 15, 2016
Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy
Larry Alphs, Henry A Nasrallah, Cynthia A Bossie, et al.
International Clinical Psychopharmacology
|
March 11, 2010
Medication satisfaction in schizophrenia: a blinded-initiation study of paliperidone extended release in patients suboptimally responsive to risperidone
Carla M Canuso, Augusto Grinspan, Amir Kalali, et al.
Journal of Medical Economics
|
August 28, 2010
Clinical characteristics and resource utilization of patients with bipolar disorder who have frequent psychiatric interventions
J Thomas Haskins, Wayne Macfadden, Norris Turner, et al.
Journal of Medical Economics
|
April 9, 2015
Cost effectiveness of paliperidone palmitate versus oral antipsychotics in patients with schizophrenia and a history of criminal justice involvement
Erik Muser, Chris M Kozma, Carmela J Benson, et al.
Bipolar Disorders
|
November 20, 2009
A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently
Wayne Macfadden, Larry Alphs, J Thomas Haskins, et al.
Page
of 12